In agreement with previous findings, ERG protein was associated with morphological phenotypes associated with poorer prognosis, including reactive stroma, invasive cribriform carcinoma, and IDC‐P [30, 31], which support that ERG protein is a biomarker for aggressive prostate cancer. Here, ERG is linked to prostate cancer.